Review Article
Role of MicroRNA-124 as a Prognostic Factor in Multiple Neoplasms: A Meta-Analysis
Table 3
Essential features and methylation outcomes of studies used in this meta-analysis.
| Study | Year | Methylation | Nonmethylation | OS | RFS/DFS | Nationality | Malignant disease | Type of miR-124 | Source of HR | HR | LL | UL | value | HR | LL | UL | value |
| Xabier | 2009 | 208 | 145 | 1.770 | 0.850 | 3.670 | <0.001 | 2.400 | 1.050 | 2.480 | <0.001 | Spain | ALL | miR-124a | SC | Gebauer | 2013 | NM | NM | NM | | | | 9.3700 | 2.680 | 32.800 | <0.001 | Germany | ccRCC | miR-124-3 | Reported | Wang | 2014 | 33 | 32 | 1.838 | 0.973 | 3.470 | 0.092 | NM | | | | China | PDAC | miR-124-1 | SC | Wang | 2014 | 34 | 31 | 3.055 | 1.596 | 5.850 | 0.002 | NM | | | | China | PDAC | miR-124-2 | Reported | Wang | 2014 | 33 | 32 | 2.499 | 1.313 | 4.757 | 0.017 | NM | | | | China | PDAC | miR-124-3 | Reported | Kim | 2017 | 48 | 109 | 1.690 | 0.990 | 2.890 | 0.053 | NM | | | | Korea | NSCLC | miR-124-1 | Reported | Kim | 2017 | 78 | 79 | 1.990 | 1.190 | 3.320 | 0.009 | NM | | | | Korea | NSCLC | miR-124-2 | Reported | Kim | 2017 | 81 | 76 | 2.100 | 1.240 | 3.550 | 0.006 | NM | | | | Korea | NSCLC | miR-124-3 | Reported | Wang | 2017 | 23 | 33 | 2.110 | 0.970 | 4.600 | 0.025 | NM | | | | China | MDS | miR-124-1 | SC | Wang | 2017 | 29 | 27 | 2.100 | 0.840 | 5.290 | 0.004 | NM | | | | China | MDS | miR-124-2 | SC | Wang | 2017 | 35 | 21 | 1.810 | 0.690 | 4.730 | 0.010 | NM | | | | China | MDS | miR-124-3 | SC |
|
|